Eric J Brandt1, Rebecca Myerson2, Marcelo Coca Perraillon3, Tamar S Polonsky4. 1. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. 2. School of Pharmacy and Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles. 3. University of Colorado Anschutz Medical Campus, Aurora. 4. Department of Medicine, University of Chicago, Chicago, Illinois.
Abstract
Importance: Trans-fatty acids (TFAs) have deleterious cardiovascular effects. Restrictions on their use were initiated in 11 New York State (NYS) counties between 2007 and 2011. The US Food and Drug Administration plans a nationwide restriction in 2018. Public health implications of TFA restrictions are not well understood. Objective: To determine whether TFA restrictions in NYS counties were associated with fewer hospital admissions for myocardial infarction (MI) and stroke compared with NYS counties without restrictions. Design, Setting, and Participants: We conducted a retrospective observational pre-post study of residents in counties with TFA restrictions vs counties without restrictions from 2002 to 2013 using NYS Department of Health's Statewide Planning and Research Cooperative System and census population estimates. In this natural experiment, we included those residents who were hospitalized for MI or stroke. The data analysis was conducted from December 2014 through July 2016. Exposure: Residing in a county where TFAs were restricted. Main Outcomes and Measures: The primary outcome was a composite of MI and stroke events based on primary discharge diagnostic codes from hospital admissions in NYS. Admission rates were calculated by year, age, sex, and county of residence. A difference-in-differences regression design was used to compare admission rates in populations with and without TFA restrictions. Restrictions were only implemented in highly urban counties, based on US Department of Agriculture Economic Research Service Urban Influence Codes. Nonrestriction counties of similar urbanicity were chosen to make a comparison population. Temporal trends and county characteristics were accounted for using fixed effects by county and year, as well as linear time trends by county. We adjusted for age, sex, and commuting between restriction and nonrestriction counties. Results: In 2006, the year before the first restrictions were implemented, there were 8.4 million adults (53.6% female) in highly urban counties with TFA restrictions and 3.3 million adults (52.3% female) in highly urban counties without restrictions. Twenty-five counties were included in the nonrestriction population and 11 in the restriction population. Three or more years after restriction implementation, the population with TFA restrictions experienced significant additional decline beyond temporal trends in MI and stroke events combined (-6.2%; 95% CI, -9.2% to -3.2%; P < .001) and MI (-7.8%; 95% CI, -12.7% to -2.8%; P = .002) and a nonsignificant decline in stroke (-3.6%; 95% CI, -7.6% to 0.4%; P = .08) compared with the nonrestriction populations. Conclusions and Relevance: The NYS populations with TFA restrictions experienced fewer cardiovascular events, beyond temporal trends, compared with those without restrictions.
Importance: Trans-fatty acids (TFAs) have deleterious cardiovascular effects. Restrictions on their use were initiated in 11 New York State (NYS) counties between 2007 and 2011. The US Food and Drug Administration plans a nationwide restriction in 2018. Public health implications of TFA restrictions are not well understood. Objective: To determine whether TFA restrictions in NYS counties were associated with fewer hospital admissions for myocardial infarction (MI) and stroke compared with NYS counties without restrictions. Design, Setting, and Participants: We conducted a retrospective observational pre-post study of residents in counties with TFA restrictions vs counties without restrictions from 2002 to 2013 using NYS Department of Health's Statewide Planning and Research Cooperative System and census population estimates. In this natural experiment, we included those residents who were hospitalized for MI or stroke. The data analysis was conducted from December 2014 through July 2016. Exposure: Residing in a county where TFAs were restricted. Main Outcomes and Measures: The primary outcome was a composite of MI and stroke events based on primary discharge diagnostic codes from hospital admissions in NYS. Admission rates were calculated by year, age, sex, and county of residence. A difference-in-differences regression design was used to compare admission rates in populations with and without TFA restrictions. Restrictions were only implemented in highly urban counties, based on US Department of Agriculture Economic Research Service Urban Influence Codes. Nonrestriction counties of similar urbanicity were chosen to make a comparison population. Temporal trends and county characteristics were accounted for using fixed effects by county and year, as well as linear time trends by county. We adjusted for age, sex, and commuting between restriction and nonrestriction counties. Results: In 2006, the year before the first restrictions were implemented, there were 8.4 million adults (53.6% female) in highly urban counties with TFA restrictions and 3.3 million adults (52.3% female) in highly urban counties without restrictions. Twenty-five counties were included in the nonrestriction population and 11 in the restriction population. Three or more years after restriction implementation, the population with TFA restrictions experienced significant additional decline beyond temporal trends in MI and stroke events combined (-6.2%; 95% CI, -9.2% to -3.2%; P < .001) and MI (-7.8%; 95% CI, -12.7% to -2.8%; P = .002) and a nonsignificant decline in stroke (-3.6%; 95% CI, -7.6% to 0.4%; P = .08) compared with the nonrestriction populations. Conclusions and Relevance: The NYS populations with TFA restrictions experienced fewer cardiovascular events, beyond temporal trends, compared with those without restrictions.
Authors: Rishi K Sood; Maria Torroella Carney; Tavora Buchman; Celina S Cabello; John F Lynch; Scott H Frank; Erika S Trapl Journal: Clin Ther Date: 2014-03-01 Impact factor: 3.393
Authors: James N Kiage; Peter D Merrill; Suzanne E Judd; Ka He; Loren Lipworth; Mary Cushman; Virginia J Howard; Edmond K Kabagambe Journal: Am J Clin Nutr Date: 2014-02-12 Impact factor: 7.045
Authors: Fumiaki Imamura; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Alice H Lichtenstein; Nirupa R Matthan; David M Herrington; David S Siscovick; Dariush Mozaffarian Journal: Am J Clin Nutr Date: 2012-10-24 Impact factor: 7.045
Authors: Sonia Y Angell; Lynn Dee Silver; Gail P Goldstein; Christine M Johnson; Deborah R Deitcher; Thomas R Frieden; Mary T Bassett Journal: Ann Intern Med Date: 2009-07-21 Impact factor: 25.391
Authors: Sirin Yaemsiri; Souvik Sen; Lesley F Tinker; Whitney R Robinson; Rhobert W Evans; Wayne Rosamond; Sylvia Wasserthiel-Smoller; Ka He Journal: Stroke Date: 2013-07-30 Impact factor: 7.914
Authors: Dong D Wang; Yanping Li; Ashkan Afshin; Marco Springmann; Dariush Mozaffarian; Meir J Stampfer; Frank B Hu; Christopher J L Murray; Walter C Willett Journal: J Nutr Date: 2019-06-01 Impact factor: 4.798
Authors: Melecia Wright; Wendy McKelvey; Christine Johnson Curtis; Lorna E Thorpe; Hubert W Vesper; Heather C Kuiper; Sonia Y Angell Journal: Am J Public Health Date: 2019-02-21 Impact factor: 9.308
Authors: Calvin Ngai; Lisa Ganguzza; Laura Flink; Kathleen Woolf; Yu Guo; Victor Acosta; Eugenia Gianos; James Slater; Joseph Burdowski; Binita Shah Journal: Am J Cardiol Date: 2018-12-18 Impact factor: 2.778